Drug Interactions
Comprehensive guide to drug-drug interactions, pharmacokinetic interactions, and interaction management.
Browse the pages below for detailed information.
tranylcypromine — Monoamine oxidase A Interaction
Drug-target interaction between tranylcypromine and Monoamine oxidase A. Synthetic organic pharmacological agent targeting this protein.
tranylcypromine — Monoamine oxidase B Interaction
Drug-target interaction between tranylcypromine and Monoamine oxidase B. Synthetic organic pharmacological agent targeting this protein.
trastuzumab — erb-b2 receptor tyrosine kinase 2 Interaction
Drug-target interaction between trastuzumab and erb-b2 receptor tyrosine kinase 2. Antibody pharmacological agent targeting this protein.
trazodone — 5-HT2A receptor Interaction
Drug-target interaction between trazodone and 5-HT2A receptor. Synthetic organic pharmacological agent targeting this protein.
trazodone — 5-HT2C receptor Interaction
Drug-target interaction between trazodone and 5-HT2C receptor. Synthetic organic pharmacological agent targeting this protein.
tremelimumab — cytotoxic T-lymphocyte-associated protein 4 (CD152) Interaction
Drug-target interaction between tremelimumab and cytotoxic T-lymphocyte-associated protein 4 (CD152). Antibody pharmacological agent targeting this protein.
treprostinil — IP receptor Interaction
Drug-target interaction between treprostinil and IP receptor. Synthetic organic pharmacological agent targeting this protein.
tretinoin — Retinoic acid receptor-α Interaction
Drug-target interaction between tretinoin and Retinoic acid receptor-α. Metabolite pharmacological agent targeting this protein.
tretinoin — Retinoic acid receptor-β Interaction
Drug-target interaction between tretinoin and Retinoic acid receptor-β. Metabolite pharmacological agent targeting this protein.
tretinoin — Retinoic acid receptor-γ Interaction
Drug-target interaction between tretinoin and Retinoic acid receptor-γ. Metabolite pharmacological agent targeting this protein.
TRH — TRH1 receptor Interaction
Drug-target interaction between TRH and TRH1 receptor. Peptide pharmacological agent targeting this protein.
triamcinolone — Glucocorticoid receptor Interaction
Drug-target interaction between triamcinolone and Glucocorticoid receptor. Synthetic organic pharmacological agent targeting this protein.
triamterene — ENaCαβγ Interaction
Drug-target interaction between triamterene and ENaCαβγ. Synthetic organic pharmacological agent targeting this protein.
triazolam — GABAA receptor α1 subunit Interaction
Drug-target interaction between triazolam and GABAA receptor α1 subunit. Synthetic organic pharmacological agent targeting this protein.
triazolam — GABAA receptor α2 subunit Interaction
Drug-target interaction between triazolam and GABAA receptor α2 subunit. Synthetic organic pharmacological agent targeting this protein.
triazolam — GABAA receptor α3 subunit Interaction
Drug-target interaction between triazolam and GABAA receptor α3 subunit. Synthetic organic pharmacological agent targeting this protein.
triazolam — GABAA receptor α5 subunit Interaction
Drug-target interaction between triazolam and GABAA receptor α5 subunit. Synthetic organic pharmacological agent targeting this protein.
trifarotene — Retinoic acid receptor-γ Interaction
Drug-target interaction between trifarotene and Retinoic acid receptor-γ. Synthetic organic pharmacological agent targeting this protein.
trifluoperazine — D2 receptor Interaction
Drug-target interaction between trifluoperazine and D2 receptor. Synthetic organic pharmacological agent targeting this protein.
trihexyphenidyl — M1 receptor Interaction
Drug-target interaction between trihexyphenidyl and M1 receptor. Synthetic organic pharmacological agent targeting this protein.
triiodothyronine — Thyroid hormone receptor-α Interaction
Drug-target interaction between triiodothyronine and Thyroid hormone receptor-α. Metabolite pharmacological agent targeting this protein.
triiodothyronine — Thyroid hormone receptor-β Interaction
Drug-target interaction between triiodothyronine and Thyroid hormone receptor-β. Metabolite pharmacological agent targeting this protein.
trilostane — hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 Interaction
Drug-target interaction between trilostane and hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2. Synthetic organic pharmacological agent targeting this protein.
trimipramine — DAT Interaction
Drug-target interaction between trimipramine and DAT. Synthetic organic pharmacological agent targeting this protein.
trimipramine — NET Interaction
Drug-target interaction between trimipramine and NET. Synthetic organic pharmacological agent targeting this protein.
trimipramine — SERT Interaction
Drug-target interaction between trimipramine and SERT. Synthetic organic pharmacological agent targeting this protein.
tripelennamine — H1 receptor Interaction
Drug-target interaction between tripelennamine and H1 receptor. Synthetic organic pharmacological agent targeting this protein.
triprolidine — H1 receptor Interaction
Drug-target interaction between triprolidine and H1 receptor. Synthetic organic pharmacological agent targeting this protein.
troglitazone — Peroxisome proliferator-activated receptor-γ Interaction
Drug-target interaction between troglitazone and Peroxisome proliferator-activated receptor-γ. Synthetic organic pharmacological agent targeting this protein.
tropicamide — M3 receptor Interaction
Drug-target interaction between tropicamide and M3 receptor. Synthetic organic pharmacological agent targeting this protein.
tropisetron — 5-HT3A Interaction
Drug-target interaction between tropisetron and 5-HT3A. Synthetic organic pharmacological agent targeting this protein.
TSH — TSH receptor Interaction
Drug-target interaction between TSH and TSH receptor. Peptide pharmacological agent targeting this protein.
tucatinib — erb-b2 receptor tyrosine kinase 2 Interaction
Drug-target interaction between tucatinib and erb-b2 receptor tyrosine kinase 2. Synthetic organic pharmacological agent targeting this protein.
tucidinostat — histone deacetylase 1 Interaction
Drug-target interaction between tucidinostat and histone deacetylase 1. Synthetic organic pharmacological agent targeting this protein.
tuvonralimab — cytotoxic T-lymphocyte-associated protein 4 (CD152) Interaction
Drug-target interaction between tuvonralimab and cytotoxic T-lymphocyte-associated protein 4 (CD152). Antibody pharmacological agent targeting this protein.
ublituximab — CD20 (membrane-spanning 4-domains, subfamily A, member 1) Interaction
Drug-target interaction between ublituximab and CD20 (membrane-spanning 4-domains, subfamily A, member 1). Antibody pharmacological agent targeting this protein.
ulipristal acetate — Progesterone receptor Interaction
Drug-target interaction between ulipristal acetate and Progesterone receptor. Synthetic organic pharmacological agent targeting this protein.
umbralisib — phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta Interaction
Drug-target interaction between umbralisib and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta. Synthetic organic pharmacological agent targeting this protein.
upadacitinib — Janus kinase 1 Interaction
Drug-target interaction between upadacitinib and Janus kinase 1. Synthetic organic pharmacological agent targeting this protein.
valbenazine — Vesicular monoamine transporter 2 Interaction
Drug-target interaction between valbenazine and Vesicular monoamine transporter 2. Synthetic organic pharmacological agent targeting this protein.
valdecoxib — COX-2 Interaction
Drug-target interaction between valdecoxib and COX-2. Synthetic organic pharmacological agent targeting this protein.
valsartan — AT1 receptor Interaction
Drug-target interaction between valsartan and AT1 receptor. Synthetic organic pharmacological agent targeting this protein.
vamorolone — Glucocorticoid receptor Interaction
Drug-target interaction between vamorolone and Glucocorticoid receptor. Synthetic organic pharmacological agent targeting this protein.
vandetanib — kinase insert domain receptor Interaction
Drug-target interaction between vandetanib and kinase insert domain receptor. Synthetic organic pharmacological agent targeting this protein.
vandetanib — ret proto-oncogene Interaction
Drug-target interaction between vandetanib and ret proto-oncogene. Synthetic organic pharmacological agent targeting this protein.
vapreotide — SST2 receptor Interaction
Drug-target interaction between vapreotide and SST2 receptor. Peptide pharmacological agent targeting this protein.
vapreotide — SST3 receptor Interaction
Drug-target interaction between vapreotide and SST3 receptor. Peptide pharmacological agent targeting this protein.
vapreotide — SST5 receptor Interaction
Drug-target interaction between vapreotide and SST5 receptor. Peptide pharmacological agent targeting this protein.
vardenafil — phosphodiesterase 5A Interaction
Drug-target interaction between vardenafil and phosphodiesterase 5A. Synthetic organic pharmacological agent targeting this protein.
varenicline — nicotinic acetylcholine receptor α4 subunit Interaction
Drug-target interaction between varenicline and nicotinic acetylcholine receptor α4 subunit. Synthetic organic pharmacological agent targeting this protein.
vasopressin — V1A receptor Interaction
Drug-target interaction between vasopressin and V1A receptor. Peptide pharmacological agent targeting this protein.
vasopressin — V1B receptor Interaction
Drug-target interaction between vasopressin and V1B receptor. Peptide pharmacological agent targeting this protein.
vasopressin — V2 receptor Interaction
Drug-target interaction between vasopressin and V2 receptor. Peptide pharmacological agent targeting this protein.
vedolizumab — integrin α4β7 Interaction
Drug-target interaction between vedolizumab and integrin α4β7. Antibody pharmacological agent targeting this protein.
vemurafenib — B-Raf proto-oncogene, serine/threonine kinase Interaction
Drug-target interaction between vemurafenib and B-Raf proto-oncogene, serine/threonine kinase. Synthetic organic pharmacological agent targeting this protein.
venetoclax — BCL2 apoptosis regulator Interaction
Drug-target interaction between venetoclax and BCL2 apoptosis regulator. Synthetic organic pharmacological agent targeting this protein.
venlafaxine — NET Interaction
Drug-target interaction between venlafaxine and NET. Synthetic organic pharmacological agent targeting this protein.
venlafaxine — SERT Interaction
Drug-target interaction between venlafaxine and SERT. Synthetic organic pharmacological agent targeting this protein.
verapamil — Cav1.1 Interaction
Drug-target interaction between verapamil and Cav1.1. Synthetic organic pharmacological agent targeting this protein.
verapamil — Cav1.2 Interaction
Drug-target interaction between verapamil and Cav1.2. Synthetic organic pharmacological agent targeting this protein.